Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Westermark
Giampaolo Merlini

Showing results (431-440 of 458) with videos related to

Pageof 46
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Bortezomib, Melphalan, and Dexamethasone for Light-Chain AmyloidosisEfstathios Kastritis, Xavier Leleu, Bertrand Arnulf, et al.
British Journal of Haematology|November 16, 2012
Response assessment in Waldenström macroglobulinaemia: update from the VIth International WorkshopRoger G Owen, Robert A Kyle, Marvin J Stone, et al.
Frontiers in Medicine|July 26, 2021
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA NetworkAntonio Vitale, Laura Obici, Marco Cattalini, et al.
Circulation. Cardiovascular Imaging|May 13, 2018
Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain AmyloidosisPaolo Milani, Angela Dispenzieri, Christopher G Scott, et al.
JACC. Cardiooncology|April 22, 2026
Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 PatientsEli Muchtar, Susan Geyer, Angela Dispenzieri, et al.
JAMA Oncology|August 1, 2024
Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain AmyloidosisEli Muchtar, Brendan Wisniowski, Susan Geyer, et al.
JAMA|December 26, 2013
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trialJohn L Berk, Ole B Suhr, Laura Obici, et al.
Blood Cancer Journal|October 17, 2020
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)María-Victoria Mateos, Shaji Kumar, Meletios A Dimopoulos, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)]Aldostefano Porcari, Cristina Chimenti, Marco Merlo, et al.
The Lancet. Oncology|July 6, 2023
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working GroupMeletios A Dimopoulos, Giampaolo Merlini, Frank Bridoux, et al.
Pageof 46

Showing results (431-440 of 458) with videos related to

Sort By:
Pageof 46
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Bortezomib, Melphalan, and Dexamethasone for Light-Chain AmyloidosisEfstathios Kastritis, Xavier Leleu, Bertrand Arnulf, et al.
British Journal of Haematology|November 16, 2012
Response assessment in Waldenström macroglobulinaemia: update from the VIth International WorkshopRoger G Owen, Robert A Kyle, Marvin J Stone, et al.
Frontiers in Medicine|July 26, 2021
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA NetworkAntonio Vitale, Laura Obici, Marco Cattalini, et al.
Circulation. Cardiovascular Imaging|May 13, 2018
Independent Prognostic Value of Stroke Volume Index in Patients With Immunoglobulin Light Chain AmyloidosisPaolo Milani, Angela Dispenzieri, Christopher G Scott, et al.
JACC. Cardiooncology|April 22, 2026
Cardiac Biomarker Complete Response in AL Amyloidosis: Characteristics, Cardiac Recovery, and Survival of 63 PatientsEli Muchtar, Susan Geyer, Angela Dispenzieri, et al.
JAMA Oncology|August 1, 2024
Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain AmyloidosisEli Muchtar, Brendan Wisniowski, Susan Geyer, et al.
JAMA|December 26, 2013
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trialJohn L Berk, Ole B Suhr, Laura Obici, et al.
Blood Cancer Journal|October 17, 2020
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)María-Victoria Mateos, Shaji Kumar, Meletios A Dimopoulos, et al.
Giornale Italiano Di Cardiologia (2006)|November 26, 2024
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)]Aldostefano Porcari, Cristina Chimenti, Marco Merlo, et al.
The Lancet. Oncology|July 6, 2023
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working GroupMeletios A Dimopoulos, Giampaolo Merlini, Frank Bridoux, et al.
Pageof 46